Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Profarmaco is an Italian pharmaceutical company specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs). Founded in Milan, the company established a strong reputation for producing high-quality synthetic APIs for global markets, particularly in therapeutic areas such as central nervous system disorders and respiratory diseases. In 2005, Profarmaco was acquired by the Swiss-based Siegfried Group, a leading global Contract Development and Manufacturing Organization (CDMO). Today, it operates as a key manufacturing site within Siegfried's global network, focusing on complex chemical synthesis and large-scale production. The company provides essential components for both generic and branded pharmaceutical products worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Profarmaco.